Several types of recurrence may be detected by radiologic assessment after treatment in patients with prostate cancer. However, early detection of distant metastasis using positron emission tomography has so far never been published. We report two patients who underwent hormone therapy or surgical resection for prostate cancer. They developed distant metastases which were detected on whole body [C-11] choline positron emission tomography/computed tomography with significant elevation of serum PSA level. In one patient, recurrent tumor of the supraclavicular node (6 mm) diminished in size after subsequent hormone therapy. Surgical resection of recurrent tumor of the lung (12 mm) was performed in the other patient, the pathology of which conf...
Background: The role of radiolabeled choline (Cho) in patients with biochemical recurrence after rad...
Salvage radiotherapy (SRT) for biochemical recurrence (BCR) following radical prostatectomy (RP) sho...
Aim. This study focuses on the potential role of [C-11] choline positron emission tomography (PET) f...
PURPOSE: An elevated serum prostate-specific antigen (PSA) level cannot distinguish between local-re...
Rationale: The evaluation of the efficacy of the treatment of men with prostate cancer is largely ba...
Context: Correct identification of metastatic sites in recurrent prostate cancer (PCa) is of crucial...
Purpose: An elevated serum PSA level cannot distinguish between local, regional recurrences and the ...
Prostate cancer (PCa) is a common malignancy in men associated with an increase in the incidence rat...
Purpose: An elevated serum PSA level cannot distinguish between local, regional recurrences and the ...
In patients treated for prostate cancer, a rising serum prostate-specific antigen (PSA) level is a f...
Prostate cancer is one of the most common malignancies. Its treatment is highly dependent on the pre...
We report a 65-year-old male with histopathologically proven prostate cancer and multiple pelvic nod...
AIM: The increase of prostate-specific antigen (PSA) after radical retropubic prostatectomy (RP) or ...
9Purpose: We evaluated the potential of PET/CT and [F-18] fluoromethylcholine (FCH) in the assessmen...
Background: The role of radiolabeled choline (Cho) in patients with biochemical recurrence after rad...
Salvage radiotherapy (SRT) for biochemical recurrence (BCR) following radical prostatectomy (RP) sho...
Aim. This study focuses on the potential role of [C-11] choline positron emission tomography (PET) f...
PURPOSE: An elevated serum prostate-specific antigen (PSA) level cannot distinguish between local-re...
Rationale: The evaluation of the efficacy of the treatment of men with prostate cancer is largely ba...
Context: Correct identification of metastatic sites in recurrent prostate cancer (PCa) is of crucial...
Purpose: An elevated serum PSA level cannot distinguish between local, regional recurrences and the ...
Prostate cancer (PCa) is a common malignancy in men associated with an increase in the incidence rat...
Purpose: An elevated serum PSA level cannot distinguish between local, regional recurrences and the ...
In patients treated for prostate cancer, a rising serum prostate-specific antigen (PSA) level is a f...
Prostate cancer is one of the most common malignancies. Its treatment is highly dependent on the pre...
We report a 65-year-old male with histopathologically proven prostate cancer and multiple pelvic nod...
AIM: The increase of prostate-specific antigen (PSA) after radical retropubic prostatectomy (RP) or ...
9Purpose: We evaluated the potential of PET/CT and [F-18] fluoromethylcholine (FCH) in the assessmen...
Background: The role of radiolabeled choline (Cho) in patients with biochemical recurrence after rad...
Salvage radiotherapy (SRT) for biochemical recurrence (BCR) following radical prostatectomy (RP) sho...
Aim. This study focuses on the potential role of [C-11] choline positron emission tomography (PET) f...